- Home
- SKIL vs ESLA Comparison
SKIL vs ESLA Comparison
Compare SKIL & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKIL | ESLA |
|---|---|---|
| Founded | 1998 | 2021 |
| Country | United States | United States |
| Employees | 2247 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.2M | 45.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SKIL | ESLA |
|---|---|---|
| Price | $5.17 | $1.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 107.3K | 37.2K |
| Earning Date | 04-07-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.11 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.43 | $0.78 |
| 52 Week High | $18.45 | $3.15 |
Technical Indicators
Market Signals| Indicator | SKIL | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 38.54 | 42.46 |
| Support Level | $4.83 | $0.97 |
| Resistance Level | $8.36 | $1.28 |
| Average True Range (ATR) | 0.86 | 0.09 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 11.65 | 40.00 |
Price Performance
Historical ComparisonAbout SKIL Skillsoft Corp.
Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.